RAC1 and gastric adenocarcinoma: Rac1 is implicated in treatment resistance in multiple cancers [37] and Rac1 inhibition increases sensitivity to doxorubicin for squamous cell carcinoma cells, 5-fluorouracil and cisplatin in gastric adenocarcinoma spheroids, and fludarabine for chronic lymphocytic leukemia (reviewed in [37]).